Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 40 /hr

★★★★★

☆☆☆☆☆

Hire Abhilash D.

Israel

USD 40 /hr

PhD Immuno-oncology Researcher | Tumor Microevironment and Metastasis Expert | EMBA-backed Strategic Insight for R&D

Profile Summary

Scientist leader with 10+ years of translational cancer research experience combining deep scientific expertise with cross-functional project leadership, strategic decision-making, and global collaboration. Currently a Postdoctoral Research Fellow at Technion leading multi-centre projects in immunotherapy resistance, therapy-induced metastasis, and biomarker development. Proven record of delivering high-impact scientific outcomes, leading 4-6 concurrent translational projects, mentoring junior scientists, and managing cross-functional collaborations including a major partnership with a clinical research group in Germany. Core Competencies: Translational research, Oncology biomarker strategy, Immuno-oncology, Scientific leadership, Cross-functional collaboration, Project management, Data interpretation, Team training, Stakeholder communication

Subject Matter Expertise

• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Cancer Research
• ☆ Cancer Biology

Services

• Writing

Writing Technical Writing

Work Experience

Pos-doctoral Research Fellow

Technion – Israel Institute of Technology

2021 - Present

Education

PhD

Advanced Centre for Treatment Research and Education in Cancer

August 2015 - June 2021

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Rotem Menachem, Igor Nudelman, Avital Vorontsova, Ido Livneh, Mor Sela, Madeleine Benguigui, Bar Manobla, Yael Shammai, Abhilash Deo, Chen Buxbaum, et al. (2025). Bone Marrow-Targeted Liposomes Loaded with Bortezomib Overcome Multiple Myeloma Resistance . ACS Nano.

C Buxbaum, A Deo, B Manobla, S Levin, S Ash, Y Shaked (2024). P16.07.A STUDYING NEUROBLASTOMA TUMOR MICROENVIRONMENT THROUGH A NOVEL PRE-CLINICAL MODEL . Neuro-Oncology.

Abhilash Deo, Jonathan P Sleeman, Yuval Shaked (2024). The role of host response to chemotherapy: resistance, metastasis and clinical implications . Clinical & Experimental Metastasis.

Madeleine Benguigui, Tim J. Cooper, Prajakta Kalkar, Sagie Schif-Zuck, Ruth Halaban, Antonella Bacchiocchi, Iris Kamer, Abhilash Deo, Bar Manobla, Rotem Menachem, et al. (2024). Interferon-stimulated neutrophils as a predictor of immunotherapy response . Cancer Cell.

Madeleine Benguigui, Avital Vorontsova, Michael Timaner, Sapir Levin, Jozafina Haj-Shomaly, Abhilash Deo, Rotem Menachem, Bar Manobla, Tim J. Cooper, Ziv Raviv, et al. (2022). Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors . Frontiers in Immunology.

Abhilash Nitin Deo, Rahul Thorat, Ajit Chandrakant Dhadve, Abhijit De, Bharat Rekhi, Pritha Ray (2022). IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

Pritha Ray, Abhilash Deo, Souvik Mukherjee, Bharat Rekhi (2020). Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer . Indian Journal of Pathology and Microbiology.

Pritha Ray, Abhilash Deo, Souvik Mukherjee, Bharat Rekhi (2020). Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer . Indian Journal of Pathology and Microbiology.

Abhilash Deo, Smrita Chaudhury, Sadhana Kannan, Bharat Rekhi, Amita Maheshwari, Sudeep Gupta, Pritha Ray (2019). Igf1R Predicts Better Survival in High-Grade Serous Epithelial Ovarian Cancer Patients and Correlates with Hctr1 Levels . Biomarkers in Medicine.

Muskaan Belani, Abhilash Deo, Preeti Shah, Manish Banker, Pawan Singal, Sarita Gupta (2018). Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells—A study in PCOS patients . The Journal of Steroid Biochemistry and Molecular Biology.